SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Abstract SARS-CoV-2 variants have continuously emerged in the face of effective vaccines. Reduced neutralization against variants raises questions as to whether other antibody functions are similarly compromised, or if they might compensate for lost neutralization activity. Here, the breadth and pot...
Main Authors: | Andrew P. Hederman, Harini Natarajan, Leo Heyndrickx, Kevin K. Ariën, Joshua A. Wiener, Peter F. Wright, Evan M. Bloch, Aaron A. R. Tobian, Andrew D. Redd, Joel N. Blankson, Amihai Rottenstreich, Gila Zarbiv, Dana Wolf, Tessa Goetghebuer, Arnaud Marchant, Margaret E. Ackerman |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-40960-0 |
Similar Items
-
Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
by: Rebekah Sherburn, et al.
Published: (2021-08-01) -
286 Genetic, laboratory and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia
by: Amihai Rottenstreich, et al.
Published: (2023-04-01) -
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine
by: Xiaohua Ye, et al.
Published: (2024-04-01) -
MxA: a broadly acting effector of interferon-induced human innate immunity
by: Liao Shuang, et al.
Published: (2022-01-01) -
Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients
by: Elizabeth A. Thompson, et al.
Published: (2023-05-01)